Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,936 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

NCT01442194

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Cullman, Alabama, United States
View all 238 locations
View Trial Details
Completed

A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting

NCT03589105

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Centre hospitalier d'Agen; Neurologie Agen, France
  • CHU Amiens Hopital Sud; Neurologie Amiens Cedex1, France
  • CHU Angers, Batiement Larrey 2, Neurologie Angers, France
  • CHU de Besancon Hopital Jean Minjoz; Service de Neurologie Besançon, France
View all 46 locations
View Trial Details
Completed

Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment

NCT03436199

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Adamas Clinical Site Cullman, Alabama, United States
  • Adamas Clinical Site Phoenix, Arizona, United States
  • Adamas Clinical Site Scottsdale, Arizona, United States
  • Adamas Clinical Site Tucson, Arizona, United States
View all 84 locations
View Trial Details

Related conditions